Literature DB >> 26146610

Dementia Prevention: optimizing the use of observational data for personal, clinical, and public health decision-making.

Penny A Dacks1, Sandrine Andrieu2, Deborah Blacker3, Aaron J Carman1, Allan M Green4, Francine Grodstein5, Victor W Henderson6, Bryan D James7, Rachel F Lane1, Joseph Lau8, Pei-Jung Lin9, Barnaby C Reeves10, Raj C Shah7, Bruno Vellas2, Kristine Yaffe11, Karin Yurko-Mauro12, Diana W Shineman1, David A Bennett7, Howard M Fillit1.   

Abstract

Worldwide, over 35 million people suffer from Alzheimer's disease and related dementias. This number is expected to triple over the next 40 years. How can we improve the evidence supporting strategies to reduce the rate of dementia in future generations? The risk of dementia is likely influenced by modifiable factors such as exercise, cognitive activity, and the clinical management of diabetes and hypertension. However, the quality of evidence is limited and it remains unclear whether specific interventions to reduce these modifiable risk factors can, in turn, reduce the risk of dementia. Although randomized controlled trials are the gold-standard for causality, the majority of evidence for long-term dementia prevention derives from, and will likely continue to derive from, observational studies. Although observational research has some unavoidable limitations, its utility for dementia prevention might be improved by, for example, better distinction between confirmatory and exploratory research, higher reporting standards, investment in effectiveness research enabled by increased data-pooling, and standardized exposure and outcome measures. Informed decision-making by the general public on low-risk health choices that could have broad potential benefits could be enabled by internet-based tools and decision-aids to communicate the evidence, its quality, and the estimated magnitude of effect.

Entities:  

Keywords:  Alzheimer’s; communication; low-risk; non-randomized studies; primary prevention

Year:  2014        PMID: 26146610      PMCID: PMC4487813     

Source DB:  PubMed          Journal:  J Prev Alzheimers Dis        ISSN: 2274-5807


  32 in total

1.  Statins for primary cardiovascular prevention.

Authors:  Dean A Seehusen
Journal:  Am Fam Physician       Date:  2011-10-01       Impact factor: 3.292

Review 2.  Systematic review of trials of the effect of continued use of oral non-selective NSAIDs on blood pressure and hypertension.

Authors:  Alan Morrison; Dena Rosen Ramey; Janet van Adelsberg; Douglas J Watson
Journal:  Curr Med Res Opin       Date:  2007-10       Impact factor: 2.580

3.  The role of a bioresource research impact factor as an incentive to share human bioresources.

Authors:  Anne Cambon-Thomsen; Gudmundur A Thorisson; Laurence Mabile
Journal:  Nat Genet       Date:  2011-06       Impact factor: 38.330

4.  Issues relating to selective reporting when including non-randomized studies in systematic reviews on the effects of healthcare interventions.

Authors:  Susan L Norris; David Moher; Barnaby C Reeves; Beverley Shea; Yoon Loke; Sarah Garner; Laurie Anderson; Peter Tugwell; George Wells
Journal:  Res Synth Methods       Date:  2012-11-13       Impact factor: 5.273

5.  The epidemiology of Alzheimer's disease: laying the foundation for drug design, conduct, and analysis of clinical trials.

Authors:  Kristine Yaffe; Michael Tocco; Ronald C Petersen; Catherine Sigler; Leah C Burns; Christel Cornelius; Ara S Khachaturian; Michael C Irizarry; Maria C Carrillo
Journal:  Alzheimers Dement       Date:  2012-05       Impact factor: 21.566

6.  Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium: Design of prospective meta-analyses of genome-wide association studies from 5 cohorts.

Authors:  Bruce M Psaty; Christopher J O'Donnell; Vilmundur Gudnason; Kathryn L Lunetta; Aaron R Folsom; Jerome I Rotter; André G Uitterlinden; Tamara B Harris; Jacqueline C M Witteman; Eric Boerwinkle
Journal:  Circ Cardiovasc Genet       Date:  2009-02

7.  SPIRIT 2013 statement: defining standard protocol items for clinical trials.

Authors:  An-Wen Chan; Jennifer M Tetzlaff; Douglas G Altman; Andreas Laupacis; Peter C Gøtzsche; Karmela Krleža-Jerić; Asbjørn Hróbjartsson; Howard Mann; Kay Dickersin; Jesse A Berlin; Caroline J Doré; Wendy R Parulekar; William S M Summerskill; Trish Groves; Kenneth F Schulz; Harold C Sox; Frank W Rockhold; Drummond Rennie; David Moher
Journal:  Ann Intern Med       Date:  2013-02-05       Impact factor: 25.391

8.  Biobanks and electronic medical records: enabling cost-effective research.

Authors:  Erica Bowton; Julie R Field; Sunny Wang; Jonathan S Schildcrout; Sara L Van Driest; Jessica T Delaney; James Cowan; Peter Weeke; Jonathan D Mosley; Quinn S Wells; Jason H Karnes; Christian Shaffer; Josh F Peterson; Joshua C Denny; Dan M Roden; Jill M Pulley
Journal:  Sci Transl Med       Date:  2014-04-30       Impact factor: 17.956

9.  Evaluating treatments in health care: the instability of a one-legged stool.

Authors:  Bonnie J Kaplan; Gerald Giesbrecht; Scott Shannon; Kevin McLeod
Journal:  BMC Med Res Methodol       Date:  2011-05-11       Impact factor: 4.615

10.  Why most published research findings are false.

Authors:  John P A Ioannidis
Journal:  PLoS Med       Date:  2005-08-30       Impact factor: 11.613

View more
  6 in total

1.  Big Data and Dementia: Charting the Route Ahead for Research, Ethics, and Policy.

Authors:  Marcello Ienca; Effy Vayena; Alessandro Blasimme
Journal:  Front Med (Lausanne)       Date:  2018-02-06

2.  Modelling idiopathic Parkinson disease as a complex illness can inform incidence rate in healthy adults: the PR EDIGT score.

Authors:  Michael G Schlossmacher; Julianna J Tomlinson; Goncalo Santos; Bojan Shutinoski; Earl G Brown; Douglas Manuel; Tiago Mestre
Journal:  Eur J Neurosci       Date:  2016-12-27       Impact factor: 3.386

3.  Association of metformin, sulfonylurea and insulin use with brain structure and function and risk of dementia and Alzheimer's disease: Pooled analysis from 5 cohorts.

Authors:  Galit Weinstein; Kendra L Davis-Plourde; Sarah Conner; Jayandra J Himali; Alexa S Beiser; Anne Lee; Andreea M Rawlings; Sanaz Sedaghat; Jie Ding; Erin Moshier; Cornelia M van Duijn; Michal S Beeri; Elizabeth Selvin; M Arfan Ikram; Lenore J Launer; Mary N Haan; Sudha Seshadri
Journal:  PLoS One       Date:  2019-02-15       Impact factor: 3.240

4.  Brain Health and Dementia Prevention: A Mixed-method Analysis.

Authors:  Zachary A Marcum; Sarah D Hohl; Shelly L Gray; Doug Barthold; Paul K Crane; Eric B Larson
Journal:  Am J Health Behav       Date:  2019-03-01

Review 5.  A call for comparative effectiveness research to learn whether routine clinical care decisions can protect from dementia and cognitive decline.

Authors:  Penny A Dacks; Joshua J Armstrong; Stephen K Brannan; Aaron J Carman; Allan M Green; M Sue Kirkman; Lawrence R Krakoff; Lewis H Kuller; Lenore J Launer; Simon Lovestone; Elizabeth Merikle; Peter J Neumann; Kenneth Rockwood; Diana W Shineman; Richard G Stefanacci; Priscilla Velentgas; Anand Viswanathan; Rachel A Whitmer; Jeff D Williamson; Howard M Fillit
Journal:  Alzheimers Res Ther       Date:  2016-08-20       Impact factor: 6.982

6.  Concurrence of High Fat Diet and APOE Gene Induces Allele Specific Metabolic and Mental Stress Changes in a Mouse Model of Alzheimer's Disease.

Authors:  Yifat Segev; Adva Livne; Meshi Mints; Kobi Rosenblum
Journal:  Front Behav Neurosci       Date:  2016-09-05       Impact factor: 3.558

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.